Dopamine receptor D1 mRNA 3' untranslated region (DRD1 mRNA 3'UTR)

The Dopamine receptor D1 (DRD1) mRNA 3' untranslated region (3'UTR) is a critical non-coding segment of the DRD1 transcript that governs post-transcriptional gene expression. It contains specific binding sites for microRNAs, such as miR-142-3p and miR-504, which regulate mRNA stability and translation efficiency (PubMed: 22908147, PubMed: 19763155). By controlling the density of D1 receptors on the cell surface, this region plays a vital role in modulating dopaminergic neurotransmission in brain regions like the striatum and prefrontal cortex. Genetic variations within the 3'UTR, including the rs11746641 polymorphism, have been linked to altered receptor expression and increased risk for nicotine dependence and schizophrenia (PubMed: 18414406, PubMed: 25650105). Dysregulation of this regulatory region is also implicated in other neuropsychiatric conditions where dopamine signaling is imbalanced, such as bipolar disorder. As a therapeutic target, the DRD1 mRNA 3'UTR is being explored for the development of RNA-based interventions, including antisense oligonucleotides and miRNA mimics. These approaches aim to restore physiological levels of the D1 receptor, offering a more nuanced method of treatment compared to traditional agonists or antagonists.

Other names

DRD1 3'UTRDopamine D1 receptor mRNA 3' untranslated regionD1R mRNA 3'UTR

Modulation of mRNA stability and translation efficiency through competitive binding or RNA interference.